AMUNNI, GIANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.417
EU - Europa 3.223
AS - Asia 1.310
SA - Sud America 170
AF - Africa 36
OC - Oceania 27
Totale 8.183
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.389
PL - Polonia 1.060
RU - Federazione Russa 721
IT - Italia 616
SG - Singapore 354
CN - Cina 329
SE - Svezia 227
HK - Hong Kong 211
IE - Irlanda 157
VN - Vietnam 143
BR - Brasile 134
KR - Corea 109
DE - Germania 108
UA - Ucraina 92
FR - Francia 79
FI - Finlandia 69
GB - Regno Unito 55
IN - India 39
AU - Australia 25
JO - Giordania 21
AR - Argentina 17
CA - Canada 17
ID - Indonesia 17
TR - Turchia 17
BD - Bangladesh 14
JP - Giappone 11
CI - Costa d'Avorio 9
NL - Olanda 9
CH - Svizzera 8
ES - Italia 7
IQ - Iraq 6
MX - Messico 6
SC - Seychelles 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
CO - Colombia 5
NP - Nepal 5
BE - Belgio 4
CL - Cile 4
EG - Egitto 4
NG - Nigeria 4
PH - Filippine 4
PY - Paraguay 4
SA - Arabia Saudita 4
CZ - Repubblica Ceca 3
DZ - Algeria 3
PK - Pakistan 3
TH - Thailandia 3
GE - Georgia 2
IL - Israele 2
LT - Lituania 2
MY - Malesia 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
UY - Uruguay 2
AT - Austria 1
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KI - Kiribati 1
LK - Sri Lanka 1
MA - Marocco 1
PA - Panama 1
PR - Porto Rico 1
PW - Palau 1
QA - Qatar 1
Totale 8.183
Salva come PNG Salva come JPEG
Città #
Warsaw 1.060
Santa Clara 866
Ashburn 387
Fairfield 259
Singapore 254
Chandler 218
Hong Kong 178
Dublin 157
Jacksonville 153
Woodbridge 150
Milan 123
Seoul 108
Houston 104
Seattle 94
Wilmington 89
Cambridge 85
Beijing 77
San Jose 69
Hefei 68
Buffalo 49
Council Bluffs 49
Ho Chi Minh City 48
Altamura 44
Lawrence 44
Ann Arbor 41
Princeton 41
Los Angeles 40
Rome 38
Lauterbourg 36
The Dalles 33
Moscow 31
Boardman 30
Paris 30
Medford 29
Munich 29
Shanghai 26
Melbourne 25
Boston 24
Hanoi 24
Helsinki 20
Florence 19
Mumbai 19
Bari 16
Dong Ket 16
San Diego 16
New York 14
Izmir 13
Jakarta 13
Turku 13
Turin 12
Dallas 11
Kent 10
Naples 10
São Paulo 10
Tokyo 10
Toronto 10
Abidjan 9
Orem 9
Salerno 9
Bologna 8
Genoa 8
Norwalk 8
Belo Horizonte 7
Figino 7
Bern 6
Catania 6
Da Nang 6
Frankfurt am Main 6
Phoenix 6
Rio de Janeiro 6
Verona 6
Brooklyn 5
Curitiba 5
Frankfurt Am Main 5
Guangzhou 5
Haiphong 5
Hillsboro 5
London 5
Miano 5
San Francisco 5
Tashkent 5
Tianjin 5
Abuja 4
Amman 4
Bengaluru 4
Campinas 4
Can Tho 4
Chennai 4
Montreal 4
Ninh Bình 4
Pontedera 4
Portoferraio 4
Torregrotta 4
Viareggio 4
West Jordan 4
Yubileyny 4
Andover 3
Aversa 3
Bozzolo 3
Brussels 3
Totale 5.672
Salva come PNG Salva come JPEG
Nome #
C-kit expression in uterine leiomyosarcomas: an immunocytochemical study of 29 cases of malignant smooth muscle tumors of the uterus. 364
C-KIT EXPRESSION AND CORRELATION WITH CHEMOTERAPY RESISTANCE IN OVARIAN CARCINOMA: AN IMMUNOCYTOCHEMICAL STUDY 355
EXPRESSION OF INDUCILE NITRIC OXIDE SYNTHASE AND CYCLOOXYGENASE-2 IN OVARIAN CANCER: CORRRELATION WITH CLINICAL OUTCOME 350
Raccomandazioni cliniche per il carcinoma mammario 322
Multidrug resistance in ovarian cancer: comparing an immunocytochemical study and ATP-tumor chemosensitivity assay. 318
THE USE OF INTRAVENOUS METHOTREXATE IN THE TREATMENT OF ECTOPIC PREGNANCY 315
Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma. 311
Utility of CDX-2 in distinguishing between primary and secondary (intestinal) mucinous ovarian carcinoma: an immunohistochemical comparison of 43 cases. 273
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas. 265
Aspetti psicosociali dell’adattamento alla malattia in pazienti oncologiche 214
Assessing psychological needs in female cancer patients: A tailored model 210
EPITHELIAL OVARIAN TUMORS IN THE REPRODUCTIVE AGE GROUP: AGE IS NOT AN INDEPENDENT PROGNOSTIC FACTOR 205
Stable disease in a patient with metastatic leiomyosarcoma treated with trabectedin 197
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors 193
COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies? 191
Uterine sarcoma: twenty-seven years of experience. 184
Estrogen and progesterone receptors expression in uterine malignant smooth muscletumors: correlation with clinical outcome. 182
Retrospective analysis of 77 patients with ovarian cancer undergoing genetic testing for BRCA1 and BRCA2 mutations 181
Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value? 181
Treatment of uterine sarcoma at the University of Florence from 1980-2001. 175
Microvessel density in ovarian carcinoma: computer image analysis in patients with shorter and longer survival. 173
THE PROTOONCOGENE C-KIT IS EXPRESSED IN LEIOMYOSARCOMAS OF THE UTERUS 171
Cyclooxygenase-2, angiogenesis, tumor cell proliferation, P-glycoprotein in advanced ovarian serous carcinoma 170
Early life events and gynaecological cancer: a pilot study 169
Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment? 168
COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates. 166
Vaginal hysterectomy and abdominal hysterectomy for treatment of endometrial cancer in the elderly 163
[Bcl-2 in ovarian carcinoma: a clinicopathologic, immunohistochemical and molecular study]. 152
Cyclooxygenase-2 expression in uterine leiomyosarcomas. 151
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards 149
HER-2/neu and bcl-2 in ovarian carcinoma: clinicopathologic, immunohistochemical, and molecular study in patients with shorter and longer survival. 149
Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: DNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors. 143
Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients. 141
DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study 139
Preoperative evaluation of tumor ploidy in endometrial carcinoma - An accurate tool to identify patients at risk for extrauterine disease and recurrence 134
Polychemotherapy in ovarian cancer: treatment with adriamycin, BCNU and cyclophosphamide vs. adrianycin and cyclophosphamide 134
Use of electronic administrative databases to measure quality indicators of breast cancer care: Experience of five regional oncology networks in Italy 123
Uterine leiomyosarcomas express KIT protein but lack mutation(s) in exon 9 ofc-KIT. 116
COX-2 and preoperative CA-125 level are strongly correlated with survival and clinical responsiveness to chemiotherapy in ovarian cancer. 113
Correlation of in vitro drug sensitivity and clinical response in ovarian carcinoma using an ATP-luminescence tumor chemosensitivity assay 111
Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network 108
HER-2\neu and Bcl-2 nel carcinoma ovarico: stusio clinico-patologico, immunoistochimico e molecolare in pazienti con breve e lunga sopravvivenza. 107
Indicators of the standard of care for melanoma: Tuscany data. 84
Totale 8.220
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.796
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.796
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022294 13 35 15 9 11 8 18 19 9 16 69 72
2022/2023833 61 156 57 66 66 154 100 52 74 12 27 8
2023/2024334 12 32 55 24 21 29 11 87 6 19 26 12
2024/20252.081 64 198 115 294 734 304 12 104 51 65 58 82
2025/20262.023 250 286 151 136 236 96 231 85 103 135 50 264
2026/202717 17 0 0 0 0 0 0 0 0 0 0 0
Totale 8.220